
Po-chih Chen
Examiner (ID: 866, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 899 |
| Issued Applications | 594 |
| Pending Applications | 121 |
| Abandoned Applications | 223 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19982727
[patent_doc_number] => 20250120949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => USE OF SPLA2 INHIBITORS TO TREAT ENVENOMATION BY SNAKES AND WASPS
[patent_app_type] => utility
[patent_app_number] => 19/000226
[patent_app_country] => US
[patent_app_date] => 2024-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19000226
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/000226 | USE OF SPLA2 INHIBITORS TO TREAT ENVENOMATION BY SNAKES AND WASPS | Dec 22, 2024 | Pending |
Array
(
[id] => 19658441
[patent_doc_number] => 20240425506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/824281
[patent_app_country] => US
[patent_app_date] => 2024-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824281
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/824281 | SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | Sep 3, 2024 | Pending |
Array
(
[id] => 20315964
[patent_doc_number] => 12454506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Benzoate derivatives
[patent_app_type] => utility
[patent_app_number] => 18/765867
[patent_app_country] => US
[patent_app_date] => 2024-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6676
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765867 | Benzoate derivatives | Jul 7, 2024 | Issued |
Array
(
[id] => 20264055
[patent_doc_number] => 12435030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => PCNA inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/755058
[patent_app_country] => US
[patent_app_date] => 2024-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 35
[patent_no_of_words] => 58663
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/755058 | PCNA inhibitors | Jun 25, 2024 | Issued |
Array
(
[id] => 19511997
[patent_doc_number] => 20240343683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => SYSTEMS AND METHODS FOR PRODUCING NITRILES
[patent_app_type] => utility
[patent_app_number] => 18/666987
[patent_app_country] => US
[patent_app_date] => 2024-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666987 | SYSTEMS AND METHODS FOR PRODUCING NITRILES | May 16, 2024 | Pending |
Array
(
[id] => 19432465
[patent_doc_number] => 20240300963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/666084
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | May 15, 2024 | Pending |
Array
(
[id] => 19432465
[patent_doc_number] => 20240300963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/666084
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | May 15, 2024 | Pending |
Array
(
[id] => 19556403
[patent_doc_number] => 20240368195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/643710
[patent_app_country] => US
[patent_app_date] => 2024-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18643710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/643710 | COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | Apr 22, 2024 | Pending |
Array
(
[id] => 19556403
[patent_doc_number] => 20240368195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/643710
[patent_app_country] => US
[patent_app_date] => 2024-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18643710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/643710 | COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | Apr 22, 2024 | Pending |
Array
(
[id] => 19763150
[patent_doc_number] => 12221423
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-02-11
[patent_title] => 3-(3-fluorophenyl)-5-(4-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/606778
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3849
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606778
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606778 | 3-(3-fluorophenyl)-5-(4-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole as an antimicrobial compound | Mar 14, 2024 | Issued |
Array
(
[id] => 20136496
[patent_doc_number] => 20250243540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-31
[patent_title] => PROBE RELATED REAGENTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/428190
[patent_app_country] => US
[patent_app_date] => 2024-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18428190
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/428190 | PROBE RELATED REAGENTS AND METHODS | Jan 30, 2024 | Pending |
Array
(
[id] => 19430893
[patent_doc_number] => 20240299391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA
[patent_app_type] => utility
[patent_app_number] => 18/424292
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424292 | COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA | Jan 25, 2024 | Pending |
Array
(
[id] => 19910241
[patent_doc_number] => 12286437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Cardiac sarcomere inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/423156
[patent_app_country] => US
[patent_app_date] => 2024-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22700
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18423156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/423156 | Cardiac sarcomere inhibitors | Jan 24, 2024 | Issued |
Array
(
[id] => 19360765
[patent_doc_number] => 20240262799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/420478
[patent_app_country] => US
[patent_app_date] => 2024-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420478
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/420478 | ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USES THEREOF | Jan 22, 2024 | Abandoned |
Array
(
[id] => 19403528
[patent_doc_number] => 20240287039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES
[patent_app_type] => utility
[patent_app_number] => 18/390494
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18390494
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/390494 | SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES | Dec 19, 2023 | Pending |
Array
(
[id] => 19403528
[patent_doc_number] => 20240287039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES
[patent_app_type] => utility
[patent_app_number] => 18/390494
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18390494
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/390494 | SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES | Dec 19, 2023 | Pending |
Array
(
[id] => 19599430
[patent_doc_number] => 20240390310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/526028
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18526028
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/526028 | ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS | Nov 30, 2023 | Abandoned |
Array
(
[id] => 20129131
[patent_doc_number] => 12371433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
[patent_app_type] => utility
[patent_app_number] => 18/522995
[patent_app_country] => US
[patent_app_date] => 2023-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21440
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 589
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18522995
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/522995 | Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases | Nov 28, 2023 | Issued |
| 18/382812 | 3-(3-FLUOROPHENYL)-5-(4-METHOXYBENZYLTHIO)-4-PHENYL-4H-1,2,4-TRIAZOLE AS AN ANTIMICROBIAL COMPOUND | Oct 22, 2023 | Abandoned |
Array
(
[id] => 20023026
[patent_doc_number] => 20250161248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/382280
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382280
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382280 | Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibitors | Oct 19, 2023 | Pending |